✦ LIBER ✦

Prednimustine (sterecyt) versus cyclophosphamide both in combination with methotrexate and 5-fluorouracil in the treatment of advanced breast cancer

✍ Scribed by Yosef, H.; Slater, A.; Keen, C.W.; Bunting, J.S.; Hope-Stone, H.; Parmar, H.; Roberts, J.T.; Termander, B.; Nilsson, B.

Book ID: 122839095
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 578 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(05)80296-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prednimustine in combination with methot

Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: A phase I–II study

✍ H. T. Mouridsen; E. Boesen 📂 Article 📅 1983 🏛 Springer US 🌐 English ⚖ 461 KB

Accelerated versus standard cyclophospha

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

✍ Baldini, E. 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 110 KB

Dose intensity of chemotherapy with cycl

Dose intensity of chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in the elderly with advanced breast cancer

✍ Beex, L.V.A.M.; Hermus, A.R.M.M.; Pieters, G.F.F.M.; van Hoesel, Q.G.C.H.; Nooy, 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Prednimustine combined with mitoxantrone

Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer

✍ Hellmut Samonigg; Herbert Stöger; Anne-Katrin Kasparek; Marianne Schmid; Johann 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 468 KB

Carcinogenic activity in rats of combine

Carcinogenic activity in rats of combined treatment with cyclophosphamide, methotrexate and 5-fluorouracil

✍ Michael Habs; Dietrich Schmähl; P. Z. Lin 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 French ⚖ 551 KB

## Abstract A total of 240 outbred Sprague‐Dawley rats were treated with 3 different doses of the cyclophosphamide‐methotrexate‐5‐fluorouracil (CMF) regimen adopted from clinical chemotherapy studies in breast cancer patients. Eighty untreated rats served as controls. Individual and total doses of

Adjuvant Therapy of Breast Cancer with P

Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil

✍ Jun-Jie Li; Gen-Hong Di; Li-Chen Tang; Ke-Da Yu; Zhen Hu; Guang-Yu Liu; Jing-Son 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB